Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M6,010Revenue (TTM) $M2,694Net Margin (%)--Altman Z-Score--
Enterprise Value $M--EPS (TTM) $3.1Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M56.6ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CVD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVDJoel Greenblatt 2015-03-31 Sold Out -0.31%$103.84 - $107.35
($106.23)
$ 106.420%Sold Out0
CVDMario Gabelli 2015-03-31 Sold Out -0.044%$103.84 - $107.35
($106.23)
$ 106.420%Sold Out0
CVDVanguard Health Care Fund 2014-12-31 Sold Out -0.5%$75.29 - $104.27
($94.07)
$ 106.4213%Sold Out0
CVDJoel Greenblatt 2014-12-31 Reduce-0.22%$75.29 - $104.27
($94.11)
$ 106.4213%Reduce -43.12%369,865
CVDRon Baron 2014-12-31 Sold Out -0.1%$75.29 - $104.27
($94.11)
$ 106.4213%Sold Out0
CVDBarrow, Hanley, Mewhinney & Strauss 2014-12-31 Sold Out -0.07%$75.29 - $104.27
($94.07)
$ 106.4213%Sold Out0
CVDMario Gabelli 2014-12-31 Buy 0.04%$75.29 - $104.27
($94.07)
$ 106.4213%New holding81,200
CVDFirst Eagle Investment 2014-12-31 Buy 0.01%$75.29 - $104.27
($94.07)
$ 106.4213%New holding20,000
CVDKen Fisher 2014-12-31 Sold Out $75.29 - $104.27
($94.07)
$ 106.4213%Sold Out0
CVDJoel Greenblatt 2014-09-30 Add0.23%$80.49 - $88.98
($85.03)
$ 106.4225%Add 82.66%650,283
CVDKen Fisher 2014-09-30 Add$80.49 - $88.98
($85.03)
$ 106.4225%Add 52.32%39,027
CVDJoel Greenblatt 2014-06-30 Add0.37%$81.55 - $106.04
($89.16)
$ 106.4219%Add 2662.77%356,011
CVDVanguard Health Care Fund 2014-06-30 Add0.05%$81.55 - $106.04
($89.37)
$ 106.4219%Add 10.67%2,486,000
CVDBarrow, Hanley, Mewhinney & Strauss 2014-06-30 Reduce$81.55 - $106.04
($89.37)
$ 106.4219%Reduce -3.32%701,680
CVDKen Fisher 2014-06-30 Buy $81.55 - $106.04
($89.16)
$ 106.4219%New holding25,621
CVDJoel Greenblatt 2014-03-31 Add0.01%$86.85 - $105.69
($98.65)
$ 106.428%Add 33.96%12,886
CVDJoel Greenblatt 2013-12-31 Buy 0.02%$83.45 - $90.51
($86.53)
$ 106.4223%New holding9,619
CVDVanguard Health Care Fund 2013-06-30 Add0.48%$71.21 - $78.88
($74.79)
$ 106.4242%Add 317.31%2,246,400
CVDVanguard Health Care Fund 2013-03-31 Buy 0.16%$57.77 - $74.32
($67.12)
$ 106.4259%New holding538,300
CVDJoel Greenblatt 2012-09-30 Sold Out -0.13%$46.39 - $49.24
($47.79)
$ 106.42123%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVD is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CVD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
NUTT BRIAN H.Principal Accounting Officer 2014-12-22Sell1,127$103.512.81view
HERRING JOSEPH LChairman and CEO 2014-12-18Sell32,692$103.023.3view
WATSON JOHN E.Corp. Sr. Vice President 2014-12-10Sell15,200$102.943.38view
Cornell Alison ACorporate Senior VP and CFO 2014-12-05Sell17,570$103.233.09view
Cimino Richard FCorp. Executive Vice President 2014-12-05Sell20,240$103.163.16view
WATSON JOHN E.Corp. Sr. Vice President 2014-12-05Sell14,500$103.213.11view
Keller Deborah LCorp. Executive Vice President 2014-12-05Sell17,770$103.133.19view
HERRING JOSEPH LChairman and CEO 2014-09-09Sell32,200$85.1325.01view
NUTT BRIAN H.Principal Accounting Officer 2014-02-25Sell210$103.223.1view
KLITGAARD WILLIAM ECorporate Sr. Vice President 2014-02-20Sell25,778$101.84.54view

Quarterly/Annual Reports about CVD:

    News about CVD:

    Articles On GuruFocus.com
    Mario Gabelli's Top 5 Stock Picks Mar 30 2015 
    Vanguard Health Care Fund Comments on Covance Inc Mar 27 2015 
    Laboratory Corporation of America Holdings Q4 Earnings Beat Market Expectations Feb 24 2015 
    Mario Gabelli's Top 5 New Stock Buys of Q4 Feb 05 2015 
    Vanguard Health Care Fund Buys Vertex Pharmaceuticals, Zoetis Inc, , Sells Cerner Corporation, AbbVi Aug 02 2013 
    Parexcel: Great Growth but a Tough Business Aug 17 2011 
    Covance Inc. Reports Operating Results (10-K) Feb 28 2011 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 13,000 Shares Dec 21 2010 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 31,300 Shares Dec 15 2010 
    Covance Inc. (CVD) Executive Vice President & COO Wendel Barr sells 19,305 Shares Nov 22 2010 

    More From Other Websites
    LabCorp Names Veteran Biopharma Executive John Ratliff CEO of Covance Drug Development Sep 20 2016
    LabCorp Q2 Results Strong, Sequenom Buyout Raises Hope Aug 19 2016
    LabCorp (LH) Tops Q2 Earnings, View Up, to Buy Sequenom Jul 27 2016
    [$$] Laboratory Corp Revenue and Profit Rise Jul 27 2016
    LabCorp Sees Balanced Growth; Covance Synergy on Track Jun 21 2016
    LabCorp (LH) Stock Price Target Boosted at Credit Suisse Jun 09 2016
    Laboratory Corp. of America Looks Pretty Healthy Jun 02 2016
    LabCorp (LH) Posts Strong Q1; Covance Synergy Continues May 17 2016
    Early Development, Central Labs Businesses: Strong Demand in 1Q16 May 08 2016
    Covance Drug Development Drives LabCorp’s 1Q16 Revenue Growth Apr 29 2016
    Rumors Of Deal Put INC Research In The Spotlight Apr 27 2016
    LabCorp (LH) Tops Q1 Earnings and Sales, Raises Guidance Apr 25 2016
    Testing LabCorp's Deal Plans Apr 19 2016
    LabCorp Hires Jonathan Zung as Group President of Clinical Development and Commercialization... Apr 11 2016
    LabCorp (LH): Revenues Strong on Balanced Organic Growth Feb 23 2016
    LabCorp's King: 2015 was 'transformative' Feb 18 2016
    LabCorp Q4 Earnings Miss, Revenues Top; Currency Bothers Feb 18 2016
    LabCorp Tops Revenues, Misses on Earnings in Q4 Feb 18 2016
    Will LabCorp (LH) Disappoint Earnings Estimates in Q4? Feb 15 2016
    ISR: Outsourced pharma research market to see accelerated growth Feb 01 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)